{"id":325,"date":"2015-05-21T18:41:56","date_gmt":"2015-05-21T18:41:56","guid":{"rendered":"http:\/\/sylentis.com\/?p=325"},"modified":"2022-07-04T15:39:34","modified_gmt":"2022-07-04T15:39:34","slug":"sylentis-esponsoriza-la-11a-reunion-anual-de-la-ots-oligonucleotide-therapeutics-society","status":"publish","type":"post","link":"https:\/\/sylentis.com\/es\/sylentis-esponsoriza-la-11a-reunion-anual-de-la-ots-oligonucleotide-therapeutics-society\/","title":{"rendered":"Sylentis esponsoriza la 11\u00aa Reuni\u00f3n Anual de la OTS (Oligonucleotide Therapeutics Society)."},"content":{"rendered":"<div class=\"annotated-body\">Sylentis esponsoriza la 11\u00aa reuni\u00f3n anual de la OTS (Oligonucleotide Therapeutics Society). \u00a0Este evento se celebrar\u00e1 en Leiden (Holanda) entre los d\u00edas 14 y 15 de Octubre. OTS es un un foro sin \u00e1nimo de lucro que persigue fomentar la comunicaci\u00f3n entre el entorno econ\u00f3mico y el empresarial en el campo de las terapias basadas en oligonucle\u00f3tidos.<\/div>\n<div class=\"annotated-body\"><\/div>\n<div class=\"annotated-body\">Puede encontrar m\u00e1s informaci\u00f3n de este evento en el siguiente enlace: \u00a0<a href=\"http:\/\/www.oligotherapeutics.org\/2015-annual-meeting\/\">http:\/\/www.oligotherapeutics.org\/2015-annual-meeting\/<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sylentis esponsoriza la 11\u00aa reuni\u00f3n anual de la OTS (Oligonucleotide Therapeutics Society). \u00a0Este evento se celebrar\u00e1 en Leiden (Holanda) entre los d\u00edas 14 y 15 de Octubre. OTS es un un foro sin \u00e1nimo de lucro que persigue fomentar la comunicaci\u00f3n entre el entorno econ\u00f3mico y el empresarial en el campo de las terapias basadas [&#8230;]\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-325","post","type-post","status-publish","format-standard","hentry","category-noticias-corporativas"],"_links":{"self":[{"href":"https:\/\/sylentis.com\/es\/wp-json\/wp\/v2\/posts\/325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sylentis.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sylentis.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sylentis.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sylentis.com\/es\/wp-json\/wp\/v2\/comments?post=325"}],"version-history":[{"count":1,"href":"https:\/\/sylentis.com\/es\/wp-json\/wp\/v2\/posts\/325\/revisions"}],"predecessor-version":[{"id":327,"href":"https:\/\/sylentis.com\/es\/wp-json\/wp\/v2\/posts\/325\/revisions\/327"}],"wp:attachment":[{"href":"https:\/\/sylentis.com\/es\/wp-json\/wp\/v2\/media?parent=325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sylentis.com\/es\/wp-json\/wp\/v2\/categories?post=325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sylentis.com\/es\/wp-json\/wp\/v2\/tags?post=325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}